CAD/CAM single-retainer monolithic zirconia ceramic resin-bonded fixed partial dentures bonded with two different resin cements: Up to 40 months clinical results of a randomized-controlled pilot study
Kılınç, Delal Dara
Gözükara Bağ, Harika Gözde
MetadataShow full item record
CitationBilir, H., Yüzbaşıoğlu, E., Sayar, G., Kılınç, D. D., Gözükara Bağ, H. G. ve Özcan, M. (2022). CAD/CAM single-retainer monolithic zirconia ceramic resin-bonded fixed partial dentures bonded with two different resin cements: Up to 40 months clinical results of a randomized-controlled pilot study. Journal of Esthetic and Restorative Dentistry, 34(7), 1122-1131. https://doi.org/10.1111/jerd.12945
Purpose This pilot study was part of a larger study planned for the future which aimed to compare the clinical success of two different resin cements used in the cementation of CAD/CAM single-retainer monolithic zirconia ceramic resin-bonded fixed dentures (RBFPDs). Methods Twenty-four RBFPDs were fabricated with monolithic zirconia (Katana (TM) Zirconia HT, Kuraray Noritake Dental Inc, Tokyo, Japan). Panavia F2.0 (PF2.0; n = 12) and Panavia V5 (PV5; n = 12) were used for cementation. The survival period was defined as the time when the restoration was placed in the mouth and lasted until an irreparable damage occurred. The repairable failures were identified as relative and irreparable failures were identified as absolute failure. The survival rate of the RBFPDs was determined by the Kaplan-Meier estimator. Statistical significance was set at p < 0.05. Results The mean observation times of the PF2.0 group and the PV5 group were 40.45 +/- 6.15 months and 40.18 +/- 6.41 months, respectively. Four failures occurred in the PF2.0 group. No failure was observed in the PV5 group. The curves of survival rate (PF2.0 = 80%, PV5 = 100%) showed no statistically significant difference (p = 0.031), although success rate (PF2.0 = 66.7%, PV5 = 100%) showed statistically significant difference (p = 0.317). Conclusion Up to 40 months mean follow-up period, performance of RBFPDs bonded with PV5 was better than with PF2.0. Clinical Significance For clinicians, it is a matter of hesitation to apply single-retainer RBFPDs. This study contains results of 40 months (minimum 32, maximum 50.47 months) clinical follow-ups of single-retainer RBFPDs. These results will enlighten clinicians about the clinical success of the resin cement type for single-retainer monolithic zirconia ceramic RBFPDs.